EUVIMEDEUVIMED entdecken
Crossref

Engineered probiotics remodel the intestinal epithelial barrier and enhance bacteriotherapy for inflammatory bowel diseases

Yu Chen, Shijie Bi, Xiaoli Zhang, Junjie Chen, Jianfeng Xin, Zhaonan Liu, Qing Guan, Peiju Qiu, Peng Wang, Jun Liu

Acta Biomaterialia · 2025-05 · 198 · 467-481

DOI: 10.1016/j.actbio.2025.04.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-05. Verfasst von Yu Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China. Hauptthemen laut MEDLINE: Probiotics, Inflammatory Bowel Diseases, Intestinal Mucosa, Escherichia coli. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Distinguished Middle-aged and Young Scientist Reward Foundation of Shandong Province, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBDs) are often associated with compromised epithelial barriers and dysregulated gut microbiota. In this study, we revealed the synergistic effect that zinc and indole-3-carbinol (I3C) have in restoring the epithelial barrier, and co-localized them on a ZI platform, which was further conjugated to the surface of Escherichia coli Nissle 1917 (EcN). The ZI@EcN formulation effectively delivered ZI to colon tissues and extended its retention in the intestines due to the colonic colonization effect of EcN, thereby promoting the sustained release of zinc and I3C for optimal synergistic effects on epithelial barrier remodeling. The restored epithelium acts as a protective barrier, preventing the infiltration of toxins and pathogens, which significantly reduces inflammation in colonic tissues. Additionally, EcN enriched the gut microbiome, increasing the abundance of beneficial bacteria while reducing that of pathogens, demonstrating its significant efficacy in gut microbiome regulation. In dextran sulfate sodium-induced mouse colitis models, ZI@EcN exhibited substantially improved prophylactic and therapeutic efficacy with favorable safety profiles, highlighting its potential for clinical applications. STATEMENT OF SIGNIFICANCE: This study highlighted the synergistic effects that zinc and indole-3-carbinol, both derived from dietary sources, have on restoring integrity of the intestinal epithelial barrier. A platform (ZI@EcN) was also developed for the targeted delivery and sustained release of zinc and indole-3-carbinol, specifically in colonic tissues, for colitis treatment. This platform not only restores the compromised intestinal epithelial barrier but also regulates the dysbiotic gut microbiota, promoting the recovery of a healthy intestinal microenvironment and showing promise in alleviating complex symptoms in a single formulation. Furthermore, the formulation demonstrated potent prophylactic and therapeutic efficacy against colitis, with favorable safety profiles, and a strong potential for clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsInflammatory Bowel DiseasesIntestinal MucosaEscherichia coliAnimalsMiceIndolesHumansGastrointestinal MicrobiomeColitisMice, Inbred C57BLZincDisease Models, AnimalDextran Sulfate

Stichwörter der Autor:innen

Colonic epithelial barrier remodelingGut microbiome regulationIndole-3-carbinolInflammatory bowel diseaseProbioticsZinc

Substanzen

Indolesindole-3-carbinolZincDextran Sulfate

Autor:innen und Institutionen

  • Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
  • Department of Integrated Traditional Chinese and Western Medicine, the People's Hospital of Huaiyin, Jinan City, Jinan 250000, China.
  • Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China; Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technolog…

Förderung

  • Distinguished Middle-aged and Young Scientist Reward Foundation of Shandong Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Ocean University of China
  • Taishan Scholar Foundation of Shandong Province

Zitieren

APA

Chen, Y., Bi, S., Zhang, X., Chen, J., Xin, J., Liu, Z., Guan, Q., Qiu, P., Wang, P., & Liu, J. (2025). Engineered probiotics remodel the intestinal epithelial barrier and enhance bacteriotherapy for inflammatory bowel diseases. Acta Biomaterialia, 198, 467-481. https://doi.org/10.1016/j.actbio.2025.04.016

Vancouver

Chen Y, Bi S, Zhang X, Chen J, Xin J, Liu Z, et al. Engineered probiotics remodel the intestinal epithelial barrier and enhance bacteriotherapy for inflammatory bowel diseases. Acta Biomaterialia. 2025;198:467-481. doi:10.1016/j.actbio.2025.04.016

BibTeX
@article{Chen2025,
  author = {Chen, Yu and Bi, Shijie and Zhang, Xiaoli and Chen, Junjie and Xin, Jianfeng and Liu, Zhaonan and Guan, Qing and Qiu, Peiju and Wang, Peng and Liu, Jun},
  title = {Engineered probiotics remodel the intestinal epithelial barrier and enhance bacteriotherapy for inflammatory bowel diseases},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {198},
  pages = {467--481},
  doi = {10.1016/j.actbio.2025.04.016}
}
Kostenlos starten →